WAM
EW icon

Wolverine Asset Management’s Edwards Lifesciences EW Stock Holding History

Wolverine Asset Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-48
Closed -$2K – 2541
2013
Q4 		$2K Hold
48
– – ﹤0.01% 2509
2013
Q3 		$2K Hold
48
– – ﹤0.01% 2515
2013
Q2 		$4K Buy
+48
New +$568 ﹤0.01% 2386

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wolverine Asset Management's EW Position: Q2 2021 in Review

Wolverine Asset Management sold out of Edwards Lifesciences (EW) in Q2 2021, closing a stake of 1,345 shares — an estimated $112K sold.

Wolverine Asset Management first reported a position in EW in Q2 2013 and held it in 7 quarters. The position peaked at $138K in Q3 2020. 1,185 funds tracked by Wall St. Rank hold EW as of Q2 2021.

  • Wolverine Asset Management reported no remaining Edwards Lifesciences position as of Q2 2021 after selling out during the quarter.
  • Wolverine Asset Management sold 1,345 Edwards Lifesciences shares in Q2 2021, an estimated $112K.
  • Wolverine Asset Management first reported a position in Edwards Lifesciences in Q2 2013 and held it in 7 quarters.
  • Wolverine Asset Management's Edwards Lifesciences position peaked at $138K in Q3 2020.
  • 1,185 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2021.

Based on Wolverine Asset Management's 13F filing for Q2 2021, filed 13 Aug 2021.